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Sesquiterpene lactones (SLs) are the active constituents of a variety of medicinal plants ????? ??? ????????????????????? ???? ???? ?????????? ??? ????????????????????? ??????????
ailments. Objective: In this study, we evaluated whether budlein A modulates the activation 
of innate and adaptive immune cells such as neutrophils and lymphocytes. Material and 
Methods: Our research group has investigated several plant species and several compounds 
???????????????????? ????????????????????????????????????????????????????????????????????
isolated from the species Aldama buddlejiformis and A. robusta (Asteraceae) and shows 
??????????????????????????????????????????????????????????????????????????????????????
derived substances modulate the activation of innate and adaptive immune cells have led 
to the development of new therapies for human diseases. Results: Budlein A inhibited 
MPO activity, IL-6, CXCL8, IL-10, and IL-12 production and induces neutrophil apoptosis. 
????????????????????????????????????????????????????????????????????????????????????????????
production, but it did not lead to cell death. Conclusions: Collectively, our results indicate 
that budlein A shows distinct immunomodulatory effects on immune cells.
Keywords: Lactones. Neutrophils. Lymphocytes.
INTRODUCTION
The ability of the immune system to respond 
to a variety of stimuli is central to its function 
in pathogen clearance and tissue repair4. The 
? ????????????????????????????????????????????
in different pathological settings is maintained by 
??????????????????????????????????????????????
signaling6, and most research has focused on 
understanding the mechanisms that regulate the 
immune response4,6,8,9. New therapeutic agents 
are currently under investigation for pathological 
conditions in which the balance between activation 
and suppression of the immune response has 
failed6. Studies have shown that plant-derived 
compounds have immunomodulatory effects 
without direct immunosuppressive action such as 
clinically used corticosteroids2,3,16,27. However, the 
mere isolation of new naturally-occurring anti-
??????????????????????????????????????????????????
drug until the exact mechanism of action and their 
possible toxic effects are completely determined9. 
Moreover, many biologically active compounds 
that do not afford a new drug or even a principal 
compound can be used as prototypes for the study 
of the mechanisms involved in a certain biological 
effect. Budlein A, a sesquiterpene lactone (SL) 
formerly isolated from the Central American species 
Aldama buddlejiformis (DC)1 and more recently 
from the South American A. robusta Gardner 
(Asteraceae), has been described as presenting 
?????????????????????????1,7,27. Recent studies have 
?????? ??????????????????????????????????????????
activities in mice22,27. Although this information is 
important for determining its properties, it provides 
restricted parameters about how this compound 
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affects other cells, adaptive immune response 
and T cell compartment. An immunomodulatory 
substance might show antibacterial activity, but 
the induced cell death could also be harmful to 
immune responses, pathogen clearance and tissue 
repair11,18. In this context, research to develop new 
????????????????? ??????? ??? ???????? ???? ???????
???????????????????????????????????????????????
by lymphocyte activation, has been stimulated. 
Given the broad information relating SLs and 
immunomodulation, we should evaluate whether 
budlein A modulates the activation of innate and 
adaptive immune cells.
MATERIAL AND METHODS
Budlein A
Budlein A (MW=374.1365) was isolated from 
the leaves of Viguiera robusta, as previously 
described27. Its chemical structure was determined 
by means of spectrometric analysis, i.e., IR, 
1H, and 13C nuclear magnetic resonance (NMR) 
spectrometry as well as comparison with an 
authentic sample and data reported in literature5. 
Analytical procedures using spectroscopy and 
chromatographic techniques indicated that the 
purity of budlein A used in this study ranged 
between 95-98%. Prior to the bioassays, budlein A 
was dissolved in dimethylsulfoxide (DMSO) (SIGMA 
– St. Louis, MO, USA) (0.1% in RPMI 1640 medium 
– GIBCO – Grand Island, NY, USA).
Healthy volunteers
We used peripheral blood from 30 healthy 
volunteers (17 men and 13 women; age ranged 
between 27-50 years). All subjects had no active 
diseases at the time of phlebotomy.  All subjects 
signed an informed consent releasing the use of 
blood for research purposes approved by the Bauru 
School of Dentistry, University of São Paulo.
Isolation of leukocytes
Peripheral blood was harvested with heparin 
(50 U/ml) from healthy subjects. Both groups of 
leukocytes were layered over two different density 
Histopaque gradients (SIGMA) and centrifuged for 
30 min at 450X g. Peripheral blood mononuclear 
????????????? ???????????????????????????????????????
Histopaque 1077) and neutrophils were isolated 
from the second buffy coat layer (onto Histopaque 
1119). Cells were then washed twice with Roswell 
Park Memorial Institute medium (RPMI) at 200 X g 
????????????????????????????????????????????????????
cells was >99% viable when assessed by Trypan 
blue exclusion.
Neutrophils culture
Neutrophils (1x106/well) from healthy donors 
were cultured in 24-well plates, in presence of 
medium only, or Lipopolysaccharide (LPS) (10 ng/
mL), N-formyl-methionine-leucine-phenylalanine 
(fMLP) (1.5 μM) in presence or absence of different 
concentrations of budlein A (1, 10 or 100 μM) or 
dexamethasone (100 μM).
T cell culture and proliferation assays
?????????????????? ??????? ????? ????? (CFSE) 
(Invitrogen – Eugene, OR, USA) labeled-PBMC 
(1x106/well) from healthy donors were cultured in 24-
well plates, in the presence of phytohaemagglutinin 
(PHA) (1 μg/ml) (SIGMA), or in presence or absence 
of different concentrations of budlein A (1, 10, or 
100 μM) or dexamethasone (100 μM), at 37°C and 
5% CO2. On day 4, the cells were harvested and the 
proliferative response of T cells was assessed by 
?????????????????????????????????????????????????
The proliferation of T cells was characterized by 
???????????????????????????????????????????????????
equally spaced peaks on a logarithmic scale. The 
data represents the percentage of proliferation of 
T cells. The cell acquisition was performed on a 
???????????????????????????????????????????????
(BD Biosciencess – San Diego, CA, USA).
Myeloperoxidase activity
Myeloperoxidase (MPO) activity was determined 
by enzymatic reaction, as previously described26. 
Neutrophils were harvested after culture and 
centrifuged at 350X g for 15 min, and the pellet 
??????????????????????????????????????????????????
and centrifuged twice at 10,000X g for 15 min at 
4°C. The MPO activity in the suspended pellet was 
assayed by measuring the change in absorbance at 
450 nm using tetramethylbenzidine (1.6 mM) and 
H2O2 (0.5 mM) (BD Biosciences).
Cytokine assays
Interleukin (IL)-2, IL-6, CXCL8, IL-10, IL-12, 
????????????? ?????????????????????????????????????
???????????????????? ?????????????????????????????
Biosciences or R&D Systems – Minneapolis, MN, 
USA), according to the manufacturer’s instructions.
Apoptosis
Cells were harvested after culture and the 
viability was analyzed by flow cytometry, as 
previously described26. The percentage of apoptotic 
cells was calculated from the proportion of 
neutrophils, as well as lymphocyte positivity for 
Annexin- V-FITC or propidium iodide (ApoScreen™ 
Annexin V-FITC kit, SouthernBiotech – Birmingham, 
AL, USA), in relation to total number of cells26.
Statistical analysis
Values are presented as mean±SEM. Statistical 
analysis was performed using ANOVA followed 
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Figure 1- Budlein A negatively regulated the neutrophil activation to fMLP and LPS. Neutrophils from healthy controls were 
?????????????? ?????????????????????? ????????????????????????????????????????????????????????????????????????????????
plus LPS. (A) Analysis of myeloperoxidase activity (MPO). B) IL-6, CXCL8, IL-10, and IL-12 production were analyzed 
by ELISA. (C) Flow cytometric analysis of apoptosis. The bars represent the mean±SEM for each volunteer individually 
????????????????
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by the Tukey’s multiple comparison test (INSTAT 
Software; GraphPad Prism, La Jolla, CA, USA). All 
values were considered ??????????????????????? 
RESULTS
Budlein A inhibits MPO activity, cytokine 
production, and induces neutrophil 
apoptosis
??? ????????? ???? ????????????????? ???????? ???
budlein A on neutrophils, cells were stimulated with 
fMLP or LPS in presence or absence of budlein A (1, 
10, or 100 μM) or dexamethasone (positive control), 
and the myeloperoxidase (MPO) activity, IL-6, 
CXCL8, IL-10, and IL-12 production and apoptosis 
were analyzed. Consistent with prior observation27, 
budlein A inhibited in a concentration-dependent 
manner the MPO activity by LPS-stimulated-
neutrophils (Fig. 1A). Our results also indicate 
that at a concentration of 10 and 100μM, budlein 
A reduced MPO activity by fMLP-stimulated 
neutrophils (Figure 1A).
Because neutrophils appear to be important 
producers of cytokines during innate immune 
response and cytokines are important mediators 
of the inflammatory process, we assessed 
whether budlein A affects cytokine and chemokine 
production by neutrophils (Figure 1B). Unstimulated 
neutrophils produced basal levels of IL-6, IL-10, 
CXCL8, and IL-12. Budlein A decreased CXCL8 
production, induced IL-10 production and did not 
alter IL-12 and IL-6 production by unstimulated 
neutrophils. After 21 h of culture, LPS and fMLP 
enhanced IL-6, CXCL8, IL-12, and IL-10 production 
by human neutrophils. In contrast, budlein A 
inhibited in a concentration-dependent manner 
IL-6 and CXCL8 production by fMLP and LPS-
stimulated neutrophils. Moreover, budlein A, at only 
100 μM concentration, inhibited IL-10 and IL-12 
production by fMLP and LPS-stimulated-neutrophils, 
while at 10 μM it inhibited IL-12 production by 
LPS-activated neutrophils (Figure 1B). To verify 
whether the results were the consequence of cell 
death, we analyzed the apoptosis of neutrophils. 
Our data showed that only budlein A at 100 μM 
concentration significantly induced neutrophil 
apoptosis (33.19±5.70%), similar to that observed 
after culture with dexamethasone (22.83±0.51%) 
(Figure 1C). Similar results were observed when 
fMLP or LPS-stimulated neutrophils were treated 
with budlein A (100 μM) (Figure 1C).
Budlein A inhibited T cell proliferation
To determine the anti-inflammatory effects 
of budlein A on lymphocytes, cells were cultured 
with PHA in presence or absence of budlein A 
(1, 10, or 100 μM) or dexamethasone (positive 
?????????????????????????????????????????????????????
?????? ??????????? ???? ??????????????? ??????????
Lymphocytes exhibit proliferative response after 
PHA stimulation, and the addition of budlein A (100 
??????????????????????????????????????????????????????
2A). These results indicate that budlein A interferes 
with PHA-induced T cell proliferation. Regarding 
cytokine production, the results evidenced that 
???????? ?? ????? ???? ?????????? ??????? ?????? ???
???? ???? ?????? ??????????? ??? ??????? ???????
lymphocytes, with similar effects to dexamethasone 
(Figure 2B).
Since budlein A negatively modulates the 
secretion of cytokines by PHA-stimulated 
lymphocytes, and this could be a consequence of 
cell death, their apoptosis was evaluated (Figure 
2C). We found that budlein A (1, 10, or 100 μM) 
does not induce lymphocyte apoptosis (Figure 
2C). These data indicate that budlein A exerts an 
important role against lymphocytes’ activation, but 
it did not induce cell death.
DISCUSSION
Although budlein A has been described as 
?????????????????????????????????????????????????
activity1,7,27?? ???????? ???????? ??? ????? ????????????
immune cells are lacking. In the present study, we 
demonstrated that budlein A inhibit neutrophils 
activation and induce cell death, but, despite also 
inhibiting lymphocyte activation, it did not induce 
lymphocyte death.
Budlein A inhibited in a concentration-dependent 
manner the release of biochemical mediators by 
neutrophils, and this activity could possibly reduce 
tissue damage caused by the enzyme24,28. The 
MPO activity can be deleterious to the host, and it 
has been implicated in the pathogenesis of many 
????????????????????21. Myeloperoxidase has also 
been established as a risk factor for many forms 
of cancer via its ability to damage/mutate cellular 
??????????????????????????????????????????????9,21. 
???????????????????????????????????? ????????????
via the inhibition of nuclear factor-kappa B (NF-
???? ??? ???? ??????????? ??? ???? ????????? ???????? ???
the p65 subunit18, impairing its activation and 
the consequent production of inflammatory 
mediators15,17.
Another important effect of budlein A on 
neutrophils shown in this study was the inhibition 
of IL-6, CXCL-8, IL-10, and IL-12 production. Pro-
???????????????????????????????????????????????
???????????????????????????????????????????????????????
? ??????????????????????????????????????????????
modulate the late events to control the immune 
response23. The imbalance between pro- and anti-
???????????? ????????? ??????????? ??????? ????????
inflammation and autoimmune diseases8,20,23. 
Imbalance in the production of inflammatory 
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Figure 2- Budlein A inhibited T cell proliferation. (A) Flow cytometric analysis of proliferative response of PBMC cultured 
with Budlein A, dexamethasone, and PHA (1.5 mM) for 96 h. (B) IL-2, IFN-gamma, TGF-beta, and IL10 concentration in 
supernatant were analyzed by ELISA. (C) Flow cytometric analysis of apoptosis. The bars represent the mean±SEM of 
????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????
when compared with the medium
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Figure 3- Graphical abstract showing effects of Budlein A on human neutrophils and lymphocytes
cytokines may allow a local inflammation to 
??????? ??? ????????????? ????????? ????????????
response8,20,21.
Because low cytokine production might have 
occurred as a consequence of cytotoxic effects 
exerted by budlein A, we analyzed the apoptosis 
of human neutrophils. Only budlein A, at the 100 
μM concentration, induces neutrophils apoptosis. 
The death of neutrophils observed in this study 
may be due to the absence of growth factors, 
particularly CXCL8, since budlein A, as well as 
other sesquiterpenes, inhibits activation of NF-
??? ???? ???? ??????????? ??? ?????????? ???????? ???
neutrophil survival1,23. In fact, 1 μM of budlein A 
???? ???? ????????????? ?????????????????? ???????????
??????????????????????????????????????????????????????
CXCL8 either. Another possible explanation could 
????????????????????????????????????????????????????
survival. Death of neutrophil induced by budlein A 
could be harmful to immune response, pathogen 
clearance, and tissue repair24,25. Neutrophils are 
?????????????????????????????????????????????????
???????????????? ??????????????????????????????????
microenvironment as well26. The precise regulation 
of neutrophil apoptosis is essential for resolution of 
??????????????????????????????????????????????????????
intracellular components that can damage healthy 
tissues10,12,19,26?????????????????????????????????????
induced neutrophil apoptosis would only be helpful 
in some chronic inflammatory diseases, since 
?????? ????????? ???????? ??????????? ????????????
mediators avoiding their resolution12,26,27. A plethora 
????????????????????? ?????????????????????????????
oxygen species or neutrophil extracellular traps) is 
produced by viable neutrophils13,28. These mediators 
???????????????????? ???????????????????????????
levels and by different ways, such as directly 
through the inhibition of cytokines, modulating their 
production or damaging surrounding tissues14,28. 
Several diseases seem to be affected by activated 
neutrophils, including rheumatoid arthritis (RA) 
and systemic lupus erythematosus (SLE)13,14,28. 
Hence, reduced numbers of activated neutrophils 
might generate a protected microenvironment from 
dramatic consequences from their uncontrolled 
???????????29.
Interestingly, despite previous studies having 
shown that high concentrations of sesquiterpene 
lactones induced apoptosis of PBMC30, we did not 
???? ???? ??????????? ??????? ??? ??????????? ??????
using three different concentrations of budlein A. 
???????? ?? ??? ???? ??? ????????????? ?????????? ????
?????????????????????????????????????????????????????
????????????????????????????????????????????????
?????????? ?? ??????????? ??????????? ??? ???????????
proliferation via other sesquiterpenes; however, the 
viability rate of the cells had not been evaluated23. 
Here, inhibition of lymphocyte proliferation might 
be a consequence of undetectable levels of IL-
2, an important cytokine inducing lymphocyte 
proliferation. Thus, budlein A might be an important 
inhibitor of uncontrolled lymphocyte proliferation 
without inducing their apoptosis. Such situation 
would facilitate their use in diseases without directly 
affecting their survival.
Therefore, our results also show that budlein 
A induced apoptosis of neutrophils but not 
lymphocytes, and indicate that budlein A shows 
distinct immunomodulatory effects on immune 
cells (Figure 3).
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CONCLUSIONS
???? ????????????????? ???????????????????? ???
budlein A reveal an important potential to the study 
of mechanisms of action and therapeutics1,5. In the 
present study, we demonstrated that budlein A 
inhibits neutrophil activation and induces cell death, 
but, despite also inhibiting lymphocyte activation, 
it did not induce lymphocyte death. Further studies 
????????????????????????????????????????????????????
?????????????????????????????????????????????????
diseases. It will be of interest to evaluate how 
the balance between these positive and negative 
effects could be regulated during the course of the 
immune response.
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